DYN — Dyne Therapeutics, Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Dyne Therapeutics,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	377	256	123	642	1,111
Prepaid Expenses
Total Current Assets	382	266	129	659	1,127
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41	38.4	33.4	30	44.8
Other Long Term Assets
Total Assets	426	306	165	691	1,187
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	28.7	28.1	51.1	42.3	50.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	57.5	54	73.8	61.4	215
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	368	252	91.3	630	972
Total Liabilities & Shareholders' Equity	426	306	165	691	1,187
Total Common Shares Outstanding